Kinetic Studies on Radical Scavenging Activity of Kaempferol Decreased by Sn(II) Binding.

Sn(II) binds to kaempferol (HKaem, 3,4',5,7-tetrahydroxy-2-(4-hydroxyphenyl)-4H-1-benzopyran-4-one) at the 3,4-site forming [Sn(II)(Kaem)2] complex in ethanol. DPPH• scavenging efficiency of HKaem is dramatically decreased by SnCl2 coordination due to formation of acid inhibiting deprotonation of HKaem as ligands and thus reduces the radical scavenging activity of the complex via a sequential proton-loss electron transfer (SPLET) mechanism. Moderate decreases in the radical scavenging of HKaem are observed by Sn(CH3COO)2 coordination and by contact between Sn and HKaem, in agreement with the increase in the oxidation potential of the complex compared to HKaem, leading to a decrease in antioxidant efficiency for fruits and vegetables with Sn as package materials.

Interfacial reaction of Sn(II) on mackinawite (FeS).

The interaction of Sn(II) with metastable, highly reactive mackinawite is a complex process due to transient changes of the mackinawite surface in the sorption process. In this work, we show that tin redox state and local structure as investigated by Sn-K X-ray absorption spectroscopy (XAS) change with pH. We observe at pH<7 that divalent Sn forms two short (2.38 Å) Sn-S bonds to the S-terminated surface of mackinawite, and two longer (2.59 Å) Sn-S bonds pointing most likely towards the solution phase, in line with a SnS4 innersphere sorption complex. Precipitation of SnS or formation of a solid solution with mackinawite could be excluded. At pH>9, Sn(II) is completely oxidized to Sn(IV) by an Fe(II)/Fe(III) (hydr)oxide, most likely green rust, forming on the surface of mackinawite. Six O atoms at 2.04 Å and 6 Fe atoms at 3.29 Å indicate a structural incorporation by green rust, with Sn(IV) substituting for Fe in the crystal structure. The transition between Sn(II) and Sn(IV) and between sulfur and oxygen coordination takes place at a pH of 7 to 8 and an Eh of -250 mV, close to the thermodynamically predicted transitions from mackinawite to Fe (hydr)oxide and from sulfide to sulfate. The uptake processes of Sn(II) by mackinawite are largely in line with the uptake processes of divalent cations with soft Lewis-acid character like Cd, Hg and Pb, and lead to a strong retention of Sn with logRd values from 5 to 7 across the investigated pH range of 5 to 11.

Measurements of relative photon emission intensities and nuclear decay data evaluation of 113Sn.

In the frame of a co-operation between CEA-LIST/LNE-LNHB (France) and IFIN-HH (Romania), the relative intensities of the photon emissions following the (113)Sn decay were accurately determined at the LNHB using high resolution X- and γ-ray spectrometers, characterized by excellent quality efficiency calibrations. Two series of measurements were carried out. The intensity of the 255 keV γ-ray relative to that of the 392 keV γ-ray was determined with an uncertainty lower than 1%. A new (113)Sn nuclear decay data evaluation was accomplished. The main results obtained are presented.

Investigation of activation cross sections of deuteron induced reactions on indium up to 40 MeV for production of a 113 Sn/113m In generator.

(113)Sn (115.09 d) is the parent nuclide of the (113)Sn/(113m)In generator system. (113m)In (99.476 min) is used in diagnostic nuclear medicine and as an Auger-electron emitter is a candidate for internal radiotherapy. Excitation functions of the (nat)In(d,x) (113 mg)Sn, (116 m)In, (ind115m)In, (114m)In, (ind113m)In, (cum111)In, (115g)Cd,(111m)Cd reactions were measured up to 40 MeV for the first time. The experimental results were compared with the curves calculated with the ALICE-D and EMPIRE-D theoretical model codes and curves given in the EAF-2007 and TENDL-2009 databases. Thick target yields, impurity levels and specific activities for the optimal energy range were deduced and compared with the same parameters of other charged particle production routes of (113)Sn.

Gamma spectrum unfolding for a NaI monitor of radioactivity in aquatic systems: experimental evaluations of the minimal detectable activity.

This paper deals with the experimental evaluation of the minimal detectable activity achievable by unfolding the gamma spectra of a NaI monitor. An aquatic monitor initially developed by the Institut des Radio-Eléments (IRE) is used for the application. Unfolding of the spectra is performed with GRAVEL, a UMG package code, on the basis of a response matrix obtained with MCNP5.1.40. Experimental data have been measured at IRE, in a 20m(3) seawater tank, for known activities of (137)Cs mixed with other gamma emitters ((40)K, (133)Ba, (113)Sn and (139)Ce). Deconvolution allows one to reduce the MDA of (137)Cs by an order of magnitude.

Blood plasma model predictions for the proposed bone-seeking radiopharmaceutical [(117m)Sn]Sn(IV)-N,N',N'-trimethylenephosphonate-poly(ethyleneimine).

In an attempt to elucidate the in vivo stability of the prospective radiopharmaceutical [(117m)Sn]Sn(IV)-PEI-MP, where PEI-MP stands for N,N',N'-trimethylenephosphonate-polyethyleneimine, glass electrode potentiometry was used to determine the stability constants of the Sn(4+) ion as complexed with a variety of physiological amino acids. In addition, linear free energy relationship (LFER) correlation plots were used to extrapolate the constants of the major blood plasma ligands, based on data from Cu(2+), Pb(2+), and Zn(2+). In so doing, a thermodynamic model of blood plasma was established for Sn(4+) from which the complexation tendencies of Sn(4+) were predicted in the event of the intravenous administration of such a drug. It was found that the Sn(IV)-PEI-MP could succumb to competition by the glutamine amino acid, which forms more stable complex(es), whilst the PEI-MP gets taken up largely by Ca(2+). Also, this study shows the value of the in vitro experiments and modeling performed for radiopharmaceutical research and for attempts to reduce the number of animal experiments.

Production of Sn-117m in the BR2 high-flux reactor.

The BR2 reactor is a 100MW(th) high-flux 'materials testing reactor', which produces a wide range of radioisotopes for various applications in nuclear medicine and industry. Tin-117m ((117m)Sn), a promising radionuclide for therapeutic applications, and its production have been validated in the BR2 reactor. In contrast to therapeutic beta emitters, (117m)Sn decays via isomeric transition with the emission of monoenergetic conversion electrons which are effective for metastatic bone pain palliation and radiosynovectomy with lesser damage to the bone marrow and the healthy tissues. Furthermore, the emitted gamma photons are ideal for imaging and dosimetry.

Labeling conditions, in vitro properties and biodistributions of various Sn-labeled complexes.

Conditions for preparing Sn-EDTMP, Sn-DTPMP, Sn-TTHMP, Sn-HEDTMP and Sn-DTPA in aqueous solution in open air environments, and their in vitro properties including adsorption on hydroxyapatite (HA) and collagen (I) and binding to bovine serum albumin (BSA) were studied using (117m)Sn and 113Sn as tracers. Biodistributions of SnO2.xH2O.yEDTMP, SnO2.xH2O.yDTPMP, SnO2.xH2O.yTTHMP, SnO2.xH2O.yHEDTMP, SnO2.xH2O.yDTPA in normal mice were also tested. Based on the above experiments, the relationship between in vitro biochemical properties and biodistributions of these SnO2.xH2O.yLigands was investigated. The results show that Sn(IV)-Ligands are prone to hydrolysis into SnO2.xH2O.yLigands in aqueous solutions in open air environments, especially when the ligand is DTPA, when the molar ratio of metal to ligand is higher than 1:200, or when the pH of the solution is higher than 10. The in vitro experiments show that all of the SnO2.xH2O.yLigands bind strongly to BSA, and the binding percentages of SnO2.xH2O.yLigands to BSA are much higher than those of the corresponding Sn(IV)-Ligands. The biodistribution data indicate that all of the SnO2.xH2O.yLigands locate mainly in bone with little uptake in liver. When the binding percentages of SnO2.xH2O.yLigands to BSA are similar, those SnO2.xH2O.yLigands with higher adsorption on HA and collagen (I) undergo lower liver uptake.

Preparation and properties of 99Tcm-exametazime using stannous ion augmentation of fractionated cold kits.

Fractionation of 99Tcm-exametazime enables several patients doses to be prepared from one vial. To overcome the disadvantages of storage at -70 degrees C, storage at higher temperatures was investigated with replacement of stannous ions before use. Kits were fractionated using a nitrogen-purged 0.9% w/v sodium chloride injection, sub-dispensed into five nitrogen-filled vials in an aseptic environment and stored at -20 degrees C. Under these conditions, exametazime vials failed quality control in approximately 1 week. However, the addition of stannous pyrophosphate solution (10 micrograms Sn(II) in 0.1 ml, prepared by aseptic dilution of a red blood cell labelling kit) immediately before 99Tcm-pertechnetate produced 90.1 +/- 1.6% (n = 8) lipophilic complex with a normal rate of decomposition. Biodistribution studies of this product in mice compared with the full kit showed identical brain and other organ uptakes. This product was used for cerebral imaging in patients with 90.5 +/- 3.3% lipophilic complex (n = 647) at approximately 3 min and produced excellent clinical results. It is concluded that stannous ion augmentation ('reboot') using approved Sn(II)-pyrophosphate kits is a viable option for institutions with facilities for aseptic preparation of fractionated exametazime kits, enabling substantial cost savings. Other advantages include removal of restrictions on generator eluate and 'rejuvenation' of expired kits.